200 related articles for article (PubMed ID: 1464728)
21. Myocardial perfusion imaging using technetium-99m radiopharmaceuticals.
Kiat H; Berman DS; Maddahi J
Radiol Clin North Am; 1993 Jul; 31(4):795-815. PubMed ID: 8337368
[TBL] [Abstract][Full Text] [Related]
22. Myocardial perfusion imaging using single-photon emission computed tomography.
Garvin AA; Cullom SJ; Garcia EV
Am J Card Imaging; 1994 Apr; 8(2):189-98. PubMed ID: 8032191
[TBL] [Abstract][Full Text] [Related]
23. ECG-gated and static technetium-99m-SESTAMIBI planar myocardial perfusion imaging: a comparison with thallium-201 and study of observer variabilities.
Verzijlbergen JF; Cramer MJ; Niemeyer MG; Ascoop CA; Van der Wall EE; Pauwels EK
Am J Physiol Imaging; 1990; 5(2):60-7. PubMed ID: 2147553
[TBL] [Abstract][Full Text] [Related]
24. Experimental studies of the physiologic properties of technetium-99m isonitriles.
Beller GA; Sinusas AJ
Am J Cardiol; 1990 Oct; 66(13):5E-8E. PubMed ID: 2145747
[TBL] [Abstract][Full Text] [Related]
25. Myocardial extraction of teboroxime: effects of teboroxime interaction with blood.
Rumsey WL; Rosenspire KC; Nunn AD
J Nucl Med; 1992 Jan; 33(1):94-101. PubMed ID: 1530970
[TBL] [Abstract][Full Text] [Related]
26. Newer technetium-99m--labeled myocardial perfusion imaging agents: clinical indications.
Bisson G; Hendel RC; Taillefer R
Am J Card Imaging; 1994 Jul; 8(3):213-22. PubMed ID: 7950172
[No Abstract] [Full Text] [Related]
27. Myocardial perfusion imaging with technetium-99m sestamibi SPECT in the evaluation of coronary artery disease.
Maddahi J; Kiat H; Van Train KF; Prigent F; Friedman J; Garcia EV; Alazraki N; DePuey EG; Nichols K; Berman DS
Am J Cardiol; 1990 Oct; 66(13):55E-62E. PubMed ID: 2145748
[TBL] [Abstract][Full Text] [Related]
28. FDA approves two new technetium-labeled cardiac agents and a pharmacologic alternative to exercise in stress-thallium studies.
Ghosh PR
J Nucl Med; 1991 May; 32(5):11N, 14N-16N, 19N. PubMed ID: 1827149
[No Abstract] [Full Text] [Related]
29. Technetium-99m-labelled HL91 and technetium-99m-labelled MIBI SPECT imaging for the detection of ischaemic viable myocardium: a preliminary study.
Liu M; Ma Z; Guo X; Zhu J; Su J
Clin Physiol Funct Imaging; 2012 Jan; 32(1):25-32. PubMed ID: 22152075
[TBL] [Abstract][Full Text] [Related]
30. Myocardial perfusion imaging with technetium-99m-sestamibi: comparative analysis of available imaging protocols.
Berman DS; Kiat HS; Van Train KF; Germano G; Maddahi J; Friedman JD
J Nucl Med; 1994 Apr; 35(4):681-8. PubMed ID: 8151394
[TBL] [Abstract][Full Text] [Related]
31. Comparison between exercise and trans-oesophageal atrial pacing in patients with coronary artery disease: technetium-99m methoxy isobutyl isonitrile simultaneous evaluation of ventricular function and myocardial perfusion.
Cuocolo A; Santomauro M; Pace L; Celentano L; Nappi A; Nicolai E; Chiariello M; Salvatore M
Eur J Nucl Med; 1992; 19(2):119-24. PubMed ID: 1532937
[TBL] [Abstract][Full Text] [Related]
32. Measurement of myocardial blood flow using a co-injection technique for technetium-99m-teboroxime, technetium-96-sestamibi and thallium-201.
Di Rocco RJ; Rumsey WL; Kuczynski BL; Linder KE; Pirro JP; Narra RK; Nunn AD
J Nucl Med; 1992 Jun; 33(6):1152-9. PubMed ID: 1534576
[TBL] [Abstract][Full Text] [Related]
33. Uptake of technetium-99m-teboroxime in cultured myocardial cells: comparison with thallium-201 and technetium-99m-sestamibi.
Maublant JC; Moins N; Gachon P; Renoux M; Zhang Z; Veyre A
J Nucl Med; 1993 Feb; 34(2):255-9. PubMed ID: 8429344
[TBL] [Abstract][Full Text] [Related]
34. [Myocardial scintigraphy with Tc-99m-MIBI for assessing the extent and severity of coronary disease: a comparison with thallium-201 and equilibrium angiocardioscintigraphy].
Leoncini M; Sciagrà R; Bisi G; Santoro GM; Fazzini PF
G Ital Cardiol; 1993 Feb; 23(2):127-38. PubMed ID: 8491353
[TBL] [Abstract][Full Text] [Related]
35. Comparison of electrocardiographic-gated technetium-99m sestamibi single-photon emission computed tomographic imaging and rest-redistribution thallium-201 in the prediction of myocardial viability.
Duncan BH; Ahlberg AW; Levine MG; McGill CC; Mann A; White MP; Mather JF; Waters DD; Heller GV
Am J Cardiol; 2000 Mar; 85(6):680-4. PubMed ID: 12000040
[TBL] [Abstract][Full Text] [Related]
36. In vitro uptake of technetium-99m-teboroxime in carcinoma cell lines and normal cells: comparison with technetium-99m-sestamibi and thallium-201.
Maublant JC; Zhang Z; Rapp M; Ollier M; Michelot J; Veyre A
J Nucl Med; 1993 Nov; 34(11):1949-52. PubMed ID: 8229240
[TBL] [Abstract][Full Text] [Related]
37. Technetium-99m Radiopharmaceuticals for Ideal Myocardial Perfusion Imaging: Lost and Found Opportunities.
Boschi A; Uccelli L; Marvelli L; Cittanti C; Giganti M; Martini P
Molecules; 2022 Feb; 27(4):. PubMed ID: 35208982
[TBL] [Abstract][Full Text] [Related]
38. Assessing myocardial reperfusion with technetium-99m-labeled myocardial perfusion agents: basic concepts and clinical applications.
Sinusas AJ; Wackers FJ
Am J Card Imaging; 1993 Mar; 7(1):24-38. PubMed ID: 10148381
[TBL] [Abstract][Full Text] [Related]
39. Clinical experience with technetium-99m teboroxime scintigraphy in patients referred for myocardial perfusion evaluation.
Itti R; Bontemps L; Sayegh Y; Delmas O; Geronicola X; Andre-Fouët X
Int J Card Imaging; 1992; 8(4):255-63. PubMed ID: 1464725
[TBL] [Abstract][Full Text] [Related]
40. Comparison of 99mTc-teboroxime with thallium for myocardial imaging in the presence of a coronary artery stenosis.
Gray WA; Gewirtz H
Circulation; 1991 Oct; 84(4):1796-807. PubMed ID: 1914115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
